Effects of Quercetin on Cardiometabolic Health
Effects of Quercetin Supplementation on Cardiometabolic Parameters
NA · University of Central Lancashire · NCT06230861
This study tests if taking Quercetin can help improve heart and metabolic health in healthy adults aged 18 to 65 compared to a placebo.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 40 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Sponsor | University of Central Lancashire (other) |
| Locations | 1 site (Preston, Lancashire) |
| Trial ID | NCT06230861 on ClinicalTrials.gov |
What this trial studies
This study investigates the potential benefits of Quercetin, a natural compound, on improving cardiometabolic outcomes in healthy adults. Participants aged 18 to 65 will be randomly assigned to receive either Quercetin or a placebo, allowing researchers to assess its effects on cardiovascular health and metabolic function. The study aims to provide a safer dietary intervention compared to traditional pharmacological treatments for cardiometabolic syndrome. By focusing on a placebo-controlled design, the research seeks to establish a clearer understanding of Quercetin's efficacy.
Who should consider this trial
Good fit: Ideal candidates for this study are healthy adults aged 18 to 65 with a BMI under 30 who do not smoke.
Not a fit: Patients with diabetes, uncontrolled hypertension, or those who are pregnant will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could offer a natural dietary intervention to improve cardiometabolic health and reduce the risk of related diseases.
How similar studies have performed: While dietary interventions for cardiometabolic health are common, this specific approach using Quercetin in a placebo-controlled setting is novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Healthy * Between 18 \& 65 years * Non-smoker * BMI \< 30 * Able to give informed consent Exclusion Criteria: * Pregnancy * Diabetes or any other metabolic/ uncontrolled hypertensive conditions * Food allergies to quercetin * Habitual consumption of quercetin * Not regularly taking medication or antioxidant supplements
Where this trial is running
Preston, Lancashire
- University of Central Lancashire — Preston, Lancashire, United Kingdom (RECRUITING)
Study contacts
- Study coordinator: Jonathan Sinclair, PhD, DSc
- Email: jksinclair@uclan.ac.uk
- Phone: +447875651533
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Cardiometabolic Syndrome